These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 28116302)

  • 1. Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know?
    Vanneste BG; Van Limbergen EJ; van Lin EN; van Roermund JG; Lambin P
    Biomed Res Int; 2016; 2016():6829875. PubMed ID: 28116302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rectal radiation dose-reduction techniques in prostate cancer: a focus on the rectal spacer.
    Leiker AJ; Desai NB; Folkert MR
    Future Oncol; 2018 Nov; 14(26):2773-2788. PubMed ID: 29939069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study.
    Weber DC; Zilli T; Vallee JP; Rouzaud M; Miralbell R; Cozzi L
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e311-8. PubMed ID: 22999271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer.
    Teh BS; Dong L; McGary JE; Mai WY; Grant W; Butler EB
    Med Dosim; 2005; 30(1):25-30. PubMed ID: 15749008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature.
    Budäus L; Bolla M; Bossi A; Cozzarini C; Crook J; Widmark A; Wiegel T
    Eur Urol; 2012 Jan; 61(1):112-27. PubMed ID: 22001105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radiotherapy of the prostate gland--old wine in a new bottle?].
    Aebersold DM
    Ther Umsch; 2006 Feb; 63(2):151-6. PubMed ID: 16514968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Image-guided intensity-modulated radiotherapy for prostate cancer: Dose constraints for the anterior rectal wall to minimize rectal toxicity.
    Peterson JL; Buskirk SJ; Heckman MG; Diehl NN; Bernard JR; Tzou KS; Casale HE; Bellefontaine LP; Serago C; Kim S; Vallow LA; Daugherty LC; Ko SJ
    Med Dosim; 2014; 39(1):12-7. PubMed ID: 24099966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose-rate brachytherapy for prostate cancer in a previously radiated patient with polyethylene glycol hydrogel spacing to reduce rectal dose: case report and review of the literature.
    Nguyen PL; Devlin PM; Beard CJ; Orio PF; O'Leary MP; Wolfsberger LD; O'Farrell DA; Sweeney CM; Hadaschik BA; Hohenfellner M; Hatiboglu G
    Brachytherapy; 2013; 12(1):77-83. PubMed ID: 22543116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogel injection reduces rectal toxicity after radiotherapy for localized prostate cancer.
    Pinkawa M; Berneking V; König L; Frank D; Bretgeld M; Eble MJ
    Strahlenther Onkol; 2017 Jan; 193(1):22-28. PubMed ID: 27632342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiobiological impact of reduced margins and treatment technique for prostate cancer in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP).
    Jensen I; Carl J; Lund B; Larsen EH; Nielsen J
    Med Dosim; 2011; 36(2):130-7. PubMed ID: 20488692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
    Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose painting to treat single-lobe prostate cancer with hypofractionated high-dose radiation using targeted external beam radiation: Is it feasible?
    Amini A; Westerly DC; Waxweiler TV; Ryan N; Raben D
    Med Dosim; 2015; 40(3):256-61. PubMed ID: 25824420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
    Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External beam radiotherapy for prostate cancer.
    Budiharto T; Haustermans K; Kovacs G
    J Endourol; 2010 May; 24(5):781-9. PubMed ID: 20370439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Benefit of intensity modulated and image-guided radiotherapy in prostate cancer].
    Latorzeff I; Mazurier J; Boutry C; Dudouet P; Richaud P; de Crevoisier R
    Cancer Radiother; 2010 Oct; 14(6-7):479-87. PubMed ID: 20797889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison study.
    Ost P; Speleers B; De Meerleer G; De Neve W; Fonteyne V; Villeirs G; De Gersem W
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):920-6. PubMed ID: 20675077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy.
    Koontz BF; Das S; Temple K; Bynum S; Catalano S; Koontz JI; Montana GS; Oleson JR
    Med Dosim; 2009; 34(3):256-60. PubMed ID: 19647638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pictorial review. Magnetic resonance for radiotherapy management and treatment planning in prostatic carcinoma.
    Lim C; Malone SC; Avruch L; Breau RH; Flood TA; Lim M; Morash C; Quon JS; Walsh C; Schieda N
    Br J Radiol; 2015 Oct; 88(1054):20150507. PubMed ID: 26279086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer.
    Lettmaier S; Lotter M; Kreppner S; Strnad A; Fietkau R; Strnad V
    Radiother Oncol; 2012 Aug; 104(2):181-6. PubMed ID: 22853851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose-rate stereotactic body radiation therapy for postradiation therapy locally recurrent prostatic carcinoma: Preliminary prostate-specific antigen response, disease-free survival, and toxicity assessment.
    Fuller DB; Wurzer J; Shirazi R; Bridge SS; Law J; Mardirossian G
    Pract Radiat Oncol; 2015; 5(6):e615-23. PubMed ID: 26059509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.